Insider at Accenture (NYSE: ACN) files to sell 660 shares
Rhea-AI Filing Summary
Accenture plc has a shareholder planning to sell 660 Class A ordinary shares on or about 01/26/2026 through UBS Financial Services on the NYSE. The filing lists an aggregate market value of $186,945.00 for these shares, compared with 660,432,542 Class A ordinary shares outstanding. The shares to be sold were originally acquired from the issuer as stock awards, including 61 shares granted on 01/05/2025 and 599 shares granted on 10/18/2023, both recorded as non-cash awards.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for ACN disclose?
The Form 144 shows that a shareholder of Accenture plc (ACN) plans to sell 660 Class A ordinary shares through UBS Financial Services on the NYSE.
How many Accenture (ACN) shares are being proposed for sale?
The notice covers a proposed sale of 660 Class A ordinary shares of Accenture plc.
What is the aggregate market value of the ACN shares to be sold?
The filing reports an aggregate market value of $186,945.00 for the 660 Class A ordinary shares planned for sale.
How many Accenture (ACN) shares are outstanding according to this filing?
The document lists 660,432,542 Class A ordinary shares outstanding for Accenture plc.
When were the Accenture (ACN) shares to be sold originally acquired?
The shares come from stock awards: 61 shares acquired on 01/05/2025 and 599 shares acquired on 10/18/2023, both from the issuer.
How were the ACN shares in this Form 144 acquired?
The filing states the securities were obtained via stock awards from the issuer, with the nature of payment noted as N/A, indicating non-cash awards.
Which broker and exchange are involved in this ACN Form 144 sale?
The planned sale uses UBS Financial Services, Inc. as broker, with trading on the NYSE.